You can buy or sell POAI and other stocks, options, and ETFs commission-free!
Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal and associated products. It operates through the following segments: Domestic, International, and Helomics. The Domestic and International segments focuses on STREAMWAY System product sales. The Helomics segment comprises of clinical testing and contract research. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Eagan, MN. The listed name for POAI is Predictive Oncology Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Mar 31, After Hours